Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up
复制标题
DOI：
10.1016/j.yebeh.2021.108069
复制
发表时间：
2021-05-30
影响因子：
2.6
通讯作者：
Liguori, Claudio
中科院分区：
文献类型：
--
作者：
Fernandes, Mariana;Dainese, Filippo;Liguori, Claudio
前言：本研究的主要目的是在真实世界的环境中，评估帕罗帕汀(PER)联合1或2种伴随的抗癫痫药物(ASM)在24个月或更长时间的随访期间对癫痫患者的有效性和耐受性。方法：这项回顾性、观察性、多中心研究收集了两组未成年人(
Introduction: The main of the present study was to assess the effectiveness and tolerability of perampanel (PER) in association with 1 or 2 concomitant antiseizure medications (ASMs) in patients with epilepsy throughout a follow-up period of 24 months or longer in a real-world setting.Methods: This retrospective, observational, multi-center study collected data from both underage (